Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Viruses|May 27, 2023
Recombinant Virus Quantification Using Single-Cell Droplet Digital PCR: A Method for Infectious Titer QuantificationKsenija Korotkaja, Anna Zajakina
Biomedicines|September 23, 2022
Recombinant Viral Vectors for Therapeutic Programming of Tumour Microenvironment: Advantages and LimitationsKarina Spunde, Ksenija Korotkaja, Anna Zajakina
Molecular Therapy. Nucleic Acids|May 8, 2025
Genetic adjuvants: A paradigm shift in vaccine development and immune modulationKarina Spunde, Ksenija Korotkaja, Irina Sominskaya, et al.
Journal of Immunology Research|June 23, 2025
Macrophage Transcriptomic Alterations Driven by Alphavirus-Based Cancer Immunotherapy VectorsKsenija Korotkaja, Darija Lapina, Zhanna Rudevica, et al.
Materials (Basel, Switzerland)|July 15, 2026
Cationic Amphiphiles with Five-Membered Heterocyclic Linkers: Synthesis, Self-Assembly, and DNA Complexation PropertiesAnda Sipola, Ksenija Korotkaja, Karlis Pajuste, et al.
International Journal of Molecular Sciences|July 14, 2023
Establishment and Characterization of Free-Floating 3D Macrophage Programming Model in the Presence of Cancer Cell SpheroidsKsenija Korotkaja, Juris Jansons, Karina Spunde, et al.
Vaccines|November 27, 2021
Alphavirus-Driven Interferon Gamma (IFNg) Expression Inhibits Tumor Growth in Orthotopic 4T1 Breast Cancer ModelOlga Trofimova, Ksenija Korotkaja, Dace Skrastina, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|September 21, 2024
Bacteria and RNA virus inactivation with a high-irradiance UV-A sourceKarina Spunde, Zhanna Rudevica, Ksenija Korotkaja, et al.
Molecular Therapy. Oncology|February 2, 2026
Virus-based IFNγ gene delivery and photodynamic therapy cooperate to remodel the tumor microenvironment and suppress breast cancerKsenija Korotkaja, Zhanna Rudevica, Darija Lapina, et al.
Bioorganic Chemistry|May 12, 2026
Exploiting PKM2-PARP1 dependency: Isoselenazolium-olaparib conjugates achieve multimodal PKM2 suppressionPavels Dimitrijevs, Marina Makrecka-Kuka, Diana Zelencova-Gopejenko, et al.
Pageof 2